Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew A Clarke

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Nature Biomedical Engineering|November 10, 2019
Prognostic hallmarks in AMLMatthew A Clarke, Jasmin Fisher
Nature Reviews. Cancer|April 29, 2020
Executable cancer models: successes and challengesMatthew A Clarke, Jasmin Fisher
Nature Communications|October 3, 2022
HOXA9 has the hallmarks of a biological switch with implications in blood cancersLaure Talarmain, Matthew A Clarke, David Shorthouse, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2019
Heterogeneity of Myc expression in breast cancer exposes pharmacological vulnerabilities revealed through executable mechanistic modelingPeter Kreuzaler, Matthew A Clarke, Elizabeth J Brown, et al.
Science Advances|April 12, 2023
Localized immune surveillance of primary melanoma in the skin deciphered through executable modelingRowan Howell, James Davies, Matthew A Clarke, et al.
NPJ Digital Medicine|February 15, 2022
Executable network of SARS-CoV-2-host interaction predicts drug combination treatmentsRowan Howell, Matthew A Clarke, Ann-Kathrin Reuschl, et al.
Cancer Research|June 24, 2026
Virtual Tumors Enable Prediction of Personalized Therapeutic Combinations for Non-Small Cell Lung CancerMatthew A Clarke, Charlie George Barker, Ashley Nicholls, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Nature Biomedical Engineering|November 10, 2019
Prognostic hallmarks in AMLMatthew A Clarke, Jasmin Fisher
Nature Reviews. Cancer|April 29, 2020
Executable cancer models: successes and challengesMatthew A Clarke, Jasmin Fisher
Nature Communications|October 3, 2022
HOXA9 has the hallmarks of a biological switch with implications in blood cancersLaure Talarmain, Matthew A Clarke, David Shorthouse, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2019
Heterogeneity of Myc expression in breast cancer exposes pharmacological vulnerabilities revealed through executable mechanistic modelingPeter Kreuzaler, Matthew A Clarke, Elizabeth J Brown, et al.
Science Advances|April 12, 2023
Localized immune surveillance of primary melanoma in the skin deciphered through executable modelingRowan Howell, James Davies, Matthew A Clarke, et al.
NPJ Digital Medicine|February 15, 2022
Executable network of SARS-CoV-2-host interaction predicts drug combination treatmentsRowan Howell, Matthew A Clarke, Ann-Kathrin Reuschl, et al.
Cancer Research|June 24, 2026
Virtual Tumors Enable Prediction of Personalized Therapeutic Combinations for Non-Small Cell Lung CancerMatthew A Clarke, Charlie George Barker, Ashley Nicholls, et al.
Pageof 1